arcadia

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE795.25-14.55 (-1.8 %)
PREV CLOSE ( ) 809.80
OPEN PRICE ( ) 812.00
BID PRICE (QTY) 796.00 (100)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 500007
TODAY'S LOW / HIGH ( )788.90 813.80
52 WK LOW / HIGH ( )723.55 1175
NSE794.55-16.45 (-2.03 %)
PREV CLOSE( ) 811.00
OPEN PRICE ( ) 813.75
BID PRICE (QTY) 794.55 (3213)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2616898
TODAY'S LOW / HIGH( ) 787.15 814.70
52 WK LOW / HIGH ( )723.65 1175.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
19Jul Lupin receives tentative approval from
Lupin has received tentative approval for its Tadalafil Tablets USP, 2.5..
16Jul UK MHRA completes inspection at Lupin’
United Kingdom (UK) Medicines and Healthcare products Regulatory Agency..
16Jul Lupin informs about press release
Lupin has informed about press release titled ‘Lupin’s Goa facility gets..
12Jul Lupin receives USFDA’s approval for Ni
Lupin has received final approval for its Nitrofurantoin Capsules USP (M..
11Jul Lupin, Boehringer Ingelheim expand par
Lupin and Boehringer Ingelheim, a German based pharma major, have expand..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit2924.613446.6
Gross Profit 3978.7 17939.3
Operating Profit 5076.822169.8
Net Sales 24776100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7275.20 (1.33%)
M.Cap ( in Cr)15459.29
Zim Laboratories (BSE)
 367.00 (4.86%)
M.Cap ( in Cr)295.79
Alkem Laboratories (BSE)
 1843.85 (0.55%)
M.Cap ( in Cr)22045.99
Hester Biosciences (BSE)
 1172.50 (0.81%)
M.Cap ( in Cr)997.43
Astrazeneca Pharma I (BSE)
 1432.50 (0.62%)
M.Cap ( in Cr)3581.25
Shareholding Pattern
PROMOTERS 47.01%
NON-INSTITUTION 15.1%
MUTUAL FUNDS/UTI 6.21%
FI/BANKS/INSURANCE 5.48%
GOVERNMENT 0.25%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM